Description

(2Z,4E,6Z,8E)-n-Butyl-3,7-Dimethyl-9-(2,6,6-Trimethyl-1-Cyclohexenyl)N Ona-2,4,6,8-Tetraenamide is a synthetic retinoid derivative, a member of the vitamin A analog family. This compound is valued for its potent biological activity and specific interaction with retinoid receptors, making it a critical intermediate in advanced pharmaceutical research and development. It is primarily sought by R&D teams in the pharmaceutical, biotechnology, and fine chemical sectors for the synthesis of novel therapeutic agents targeting dermatological conditions, oncology, and metabolic disorders.

Application

• Pharmaceutical Intermediate: Key building block for the synthesis of novel retinoid-based drugs targeting skin diseases (e.g., psoriasis, acne) and cancers.
• Biochemical Research: Used as a reference standard or active ligand in studies of retinoid receptor (RAR/RXR) signaling pathways and gene expression.
• Cosmeceutical R&D: Investigated for potential application in high-performance anti-aging and skin-repair formulations.
• Chemical Synthesis: Serves as a versatile chiral intermediate in the total synthesis of complex natural products and specialized organic molecules.
• Agrochemical Research: Explored for developing new plant growth regulators or bioactive agents due to its structural similarity to carotenoid derivatives.

Basic Information

Item	Details
Product Name	(2Z,4E,6Z,8E)-n-Butyl-3,7-Dimethyl-9-(2,6,6-Trimethyl-1-Cyclohexenyl)N Ona-2,4,6,8-Tetraenamide
CAS No.	84680-30-8
Molecular Formula	C26H39NO
Molecular Weight	381.60 g/mol
Synonyms	n-Butyl (2Z,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenamide; Retinoid Amide Derivative; 9-(2,6,6-Trimethyl-1-cyclohexenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid n-butylamide; Butyl retinamide analog; (all-E)-N-Butylretinamide (isomeric form); Vitamin A butylamide derivative; 84680-30-8 (CAS Name); Retinoic acid butylamide
EINECS	Contact for details

Quality Control

Our (2Z,4E,6Z,8E)-n-Butyl-3,7-Dimethyl-9-(2,6,6-Trimethyl-1-Cyclohexenyl)N Ona-2,4,6,8-Tetraenamide is produced under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure high purity, correct isomeric composition, and batch-to-batch consistency, meeting the stringent requirements for pharmaceutical R&D. Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are available upon request. We can support development with custom purity grades, including research and pharmaceutical intermediate specifications.

Storage

Preserve in a tightly closed container, protected from light. Store under an inert atmosphere (e.g., nitrogen or argon) at a controlled room temperature (15-25°C) to minimize oxidation and degradation. The container should be kept in a cool, dry, and well-ventilated area, away from heat sources and incompatible materials.

Specification

Item	Specification
Appearance	Yellow to orange crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0% (Total of specified isomers)
Isomeric Composition (HPLC)	Specified per grade requirement
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.